Akums launches generic formulation to treat migraine
时间:2024-06-26 09:49:15 阅读(143)
Akums Drugs & Pharmaceuticals Ltd., a contract manufacturing pharmaceutical company, on Friday announced that it has launched the Lasmiditan tablet which is prescribed to treat migraine. This medication has received approvals from the Drug Controller General of India (DCGI) and the United States Food and Drug Administration (USFDA).
It is the generic formulation of Eli Lilly’s REYVOW which is indicated for treatment of acute migraine.
In a 2019 report, it was revealed that headache disorders, including both migraines and tension-type headaches, have emerged as the most prevalent neurological conditions in India, affecting an astonishing 488 million individuals.
The International Headache Society (IHS) outlines criteria for diagnosing migraine, including specific characteristics and associated symptoms observed in at least five attacks. Two main subtypes, migraine without aura and migraine with aura, present distinct features, with the latter involving focal neurological symptoms preceding or accompanying the headache.
“Migraine poses a significant global impact. According to a 2019 report, headache disorders, encompassing migraine and tension-type headaches, emerged as the most widespread neurological conditions in India, impacting a staggering 488 million individuals. Despite this substantial prevalence and the resulting disability, migraine awareness among patients remains inadequate. Compounded by frequent misdiagnosis as other headache disorders, these factors contribute to an increased burden associated with migraine. In light of this, Akums aims to provide a solution for managing this condition with the introduction of the Lasmiditan tablet,” Sanjeev Jain, Joint Managing Director, Akums Drugs & Pharmaceuticals Ltd., said.
猜你喜欢
- Adani Group, Ambuja Cement, Yes Bank, IndusInd Bank, Dilip Buildcon, Zydus, JSW Steel stocks in focus
- Adani Enterprises FPO fully subscribed on last day, bidding still open; shares rise over 3%
- A Christmas bonus for the UK’s struggling retailers- Andrea Felsted
- Electronics Mart India IPO opens on Tuesday, GMP rises; should you subscribe-
- Yes Bank to issue securities worth Rs 8,898 crore to Carlyle, Advent
- DXY continues to gain momentum; currencies to be volatile after Fed Chair statement, USDINR to trade sideways
- Adani Group shares beat Nifty- Which Gautam Adani stock gave investors best returns in 2022-
- ZEEL, HDFC Bank, Axis Bank, Jindal Steel, Sanofi India, Titan stocks in focus
- Adani group stocks continue to bleed, fall up to 19%; Adani Enterprises, Ports buck trend, shares jump 7%